Abdul Manaf Ali Selected Research

goniothalamin

1/2022	Combination of Goniothalamin and Sol-Gel-Derived Bioactive Glass 45S5 Enhances Growth Inhibitory Activity via Apoptosis Induction and Cell Cycle Arrest in Breast Cancer Cells MCF-7.
4/2016	Goniothalamin induces cell cycle arrest and apoptosis in H400 human oral squamous cell carcinoma: A caspase-dependent mitochondrial-mediated pathway with downregulation of NF-κβ.
1/2013	Goniothalamin selectively induces apoptosis on human hepatoblastoma cells through caspase-3 activation.
1/2013	Induction of caspase-9, biochemical assessment and morphological changes caused by apoptosis in cancer cells treated with goniothalamin extracted from Goniothalamus macrophyllus.
1/2012	Apoptosis induction, cell cycle arrest and in vitro anticancer activity of gonothalamin in a cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abdul Manaf Ali Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2003
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2009
3	Mouth Neoplasms (Oral Cancer) 12/2017 - 04/2016
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
2	Wounds and Injuries (Trauma) 01/2020 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 12/2017 - 04/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013 - 01/2012
1	Inflammation (Inflammations) 02/2020
1	Cicatrix (Scar) 01/2020
1	Body Weight (Weight, Body) 10/2019
1	Chronic Disease (Chronic Diseases) 12/2017
1	Skin Diseases (Skin Disease) 06/2013
1	Hepatoblastoma 01/2013
1	Liver Neoplasms (Liver Cancer) 01/2013
1	Leukemia 01/2012
1	Infections 08/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2007
1	Brain Neoplasms (Brain Tumor) 04/2007
1	Carcinogenesis 04/2007
1	Glioma (Gliomas) 07/2005
1	Hemiplegia (Spastic Hemiplegia) 07/2005

Drug/Important Bio-Agent (IBA)

8	Antineoplastic Agents (Antineoplastics)IBA 10/2019 - 01/2003
5	goniothalaminIBA 01/2022 - 01/2012
3	Fluorouracil (Carac)FDA LinkGeneric 10/2019 - 01/2019
2	Ointments (Pastes)IBA 01/2020 - 01/2020
2	nordamnacanthalIBA 12/2017 - 10/2016
2	damnacanthalIBA 12/2017 - 10/2016
2	TriterpenesIBA 01/2012 - 05/2010
2	Codon (Codons)IBA 04/2007 - 07/2005
1	IronIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	HepcidinsIBA 01/2023
1	Polymethyl Methacrylate (Sol)IBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	CollagenIBA 01/2020
1	AzoxymethaneIBA 10/2019
1	AnthraquinonesIBA 12/2017
1	CaspasesIBA 04/2016
1	Caspase 9IBA 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Betulinic AcidIBA 01/2012
1	LactonesIBA 01/2012
1	phorbolIBA 05/2010
1	Butyric Acid (Butanoic Acid)IBA 05/2010
1	campesterolIBA 05/2010
1	Phytosterols (Plant Sterols)IBA 05/2010
1	gamma-sitosterol (beta-sitosterol)IBA 05/2010
1	StigmasterolIBA 05/2010
1	AcidsIBA 05/2010
1	maslinic acidIBA 05/2010
1	AlkaloidsIBA 08/2009
1	Vancomycin FDA LinkGeneric 08/2009
1	Monoclonal AntibodiesIBA 06/2009
1	ParaffinIBA 06/2009
1	Immunoglobulin M (IgM)IBA 06/2009
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	NucleotidesIBA 04/2007
1	Cyclin D1IBA 04/2007
1	ErbB Receptors (EGF Receptor)IBA 07/2005

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2003
2	Radiotherapy 10/2019 - 07/2005
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2013